Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

Gene-expression profiling and next-generation sequencing have defined diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis, as a heterogeneous group of subentities. Despite ongoing explosions of data illuminating disparate pathogenic mechanisms, however, the five-drug chemoimmun...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Amit Dipak, Peters, Tara L., Li, Lingxiao, Rajan, Soumya Sundara, Choudhari, Ramesh, Puvvada, Soham D., Schatz, Jonathan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411687/
https://www.ncbi.nlm.nih.gov/pubmed/28487884
http://dx.doi.org/10.1101/mcs.a001719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411687/
https://www.ncbi.nlm.nih.gov/pubmed/28487884
http://dx.doi.org/10.1101/mcs.a001719

Ejemplares similares